Anavex Life Sciences Corp (AVXL)

[tradeherpete]

I think she left out the safety factor which is a multiplier for every other aspect, especially the increased efficacy. Increased efficacy with SAFETY.

She lists out the other indications and diminishes their value while making no mention of possible off label uses for other multiple indications once the MOA is revealed fully, possibly in the peer reviewed article.

And as already pointed out, brain volume, pill format.

It must have taken a lot of effort to omit the best features while droning on about the modest increased efficacy compared to what's out there.

C minus